Related Experiment Video
Updated: Jun 27, 2026

19:57
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
First observation of HIV type 1 drug resistance mutations in Algeria
Salima Bouzeghoub1, Valerie Jauvin, Patricia Pinson
1Institut Pasteur, Alger, Algérie.
AIDS Research and Human Retroviruses
|November 27, 2008
Abstract:
This study demonstrates for the first time HIV-1 resistance mutations to all classes of antiretroviral drugs available in Algeria (NRTIs, NNRTIs, PIs) in treated patients at failure. Moreover, it is shown that mutations to NRTIs and PIs can be observed in untreated patients in this country where there is high HIV-1 diversity.

